{"slideshow_credits": null, "snippet": "A New York group is expected to announce Wednesday that it has filed challenges to patents on Sovaldi in Argentina, Brazil, China, Russia and Ukraine.", "abstract": "Patient activist groups in Argentina, Brazil, China, Russia and Ukraine will file challenges seeking to void patents for Gilead Sciences blockbuster hepatitis C drug Sovaldi; argue that $84,000 price tag for course of treatment is prohibitive; actions are sign that controversy surrounding the drug in United States has spread abroad.", "section_name": "Business Day", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2015/05/20/business/high-cost-of-hepatitis-c-drug-prompts-a-call-to-void-its-patents.html", "lead_paragraph": "A New York group is expected to announce Wednesday that it has filed challenges to patents on Sovaldi in Argentina, Brazil, China, Russia and Ukraine.", "headline": {"main": "High Cost of Sovaldi Hepatitis C Drug Prompts a Call to Void Its Patents", "print_headline": "High Cost of Hepatitis C Drug Prompts a Call to Void Its Patents"}, "_id": "555bdca338f0d82290bae66c", "word_count": "905", "multimedia": [{"height": 126, "url": "images/2015/05/20/business/20GILEAD/20GILEAD-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/05/20/business/20GILEAD/20GILEAD-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 480, "url": "images/2015/05/20/business/20GILEAD/20GILEAD-articleLarge.jpg", "legacy": {"xlarge": "images/2015/05/20/business/20GILEAD/20GILEAD-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "480"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/05/20/business/20GILEAD/20GILEAD-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/05/20/business/20GILEAD/20GILEAD-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-05-20T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Hepatitis", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Gilead Sciences Inc", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Sovaldi (Drug)", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Inventions and Patents", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "5"}, {"name": "glocations", "value": "Argentina", "is_major": "N", "rank": "6"}, {"name": "glocations", "value": "Brazil", "is_major": "N", "rank": "7"}, {"name": "glocations", "value": "China", "is_major": "N", "rank": "8"}, {"name": "glocations", "value": "Russia", "is_major": "N", "rank": "9"}, {"name": "glocations", "value": "Ukraine", "is_major": "N", "rank": "10"}], "blog": [], "subsection_name": null, "type_of_material": "News"}